16 17 18 19 facilitates not only understanding the cancer development but finding potential 43 therapeutic targets. Briefly, this framework has implications for improved modeling of 44 tumor evolution and the importance of inclusion of subclonal CNAs. 45 46 Discussion 595
Abstract 20
Multistage tumorigenesis is a dynamic process characterized by the accumulation 21 of mutations. Thus, a tumor mass is composed of genetically divergent cell subclones. 22
With the advancement of next-generation sequencing (NGS), mathematical models 23 have been recently developed to decompose tumor subclonal architecture from a 24 collective genome sequencing data. Most of the methods focused on single-nucleotide 25 variants (SNVs). However, somatic copy number aberrations (CNAs) also play critical 26 roles in carcinogenesis. Therefore, further modeling subclonal CNAs composition 27 would hold the promise to improve the analysis of tumor heterogeneity and cancer 28 evolution. To address this issue, we developed a two-way mixture Poisson model, 29
named CloneDeMix for the deconvolution of read-depth information. It can infer the 30 subclonal copy number, mutational cellular prevalence (MCP), subclone composition, 31 and the order in which mutations occurred in the evolutionary hierarchy. The 32 performance of CloneDeMix was systematically assessed in simulations. As a result, 33 the accuracy of CNA inference was nearly 93% and the MCP was also accurately 34 restored. Furthermore, we also demonstrated its applicability using head and neck 35 cancer samples from TCGA. Our results inform about the extent of subclonal CNA 36 diversity, and a group of candidate genes that probably initiate lymph node metastasis 37 during tumor evolution was also discovered. Most importantly, these driver genes are 38 located at 11q13.3 which is highly susceptible to copy number change in head and neck 39 cancer genomes. This study successfully estimates subclonal CNAs and exhibit the 40 evolutionary relationships of mutation events. By doing so, we can track tumor 41 heterogeneity and identify crucial mutations during evolution process. Hence, it 42 Introduction 47 Cancer, a dynamic disease, is characterized by unusual cells with somatic 48 mutations. These mutations are caused by environmental factors accumulated during 49 an individual's lifetime; this accumulation of mutational events results in a large degree 50 of genetic heterogeneity among cancer cells. The intratumor heterogeneity causes 51 difficulties in devising personalized treatment strategies. 52
To decipher intratumor heterogeneity, understanding how cancer evolves is a key 53 step. The hypothesis for the somatic evolution of cancer was proposed in the 1970s [1] . 54
It states that all tumor cells descend from a single founder cell, and cells with some 55 advantageous mutations become more competitive than normal cells for growth and 56 clonal expansion. This hypothesis could also be formed through random drift. Gradually, 57 subsequent clonal expansion occurs, and the tumor evolves into an organization of 58 multiple cell subpopulations. Understanding clonal evolution in cancer is one of the 59 goals of cancer medicine [2] . Presently, sequencing technology enables performing a 60 large-scale molecular profiling of tumors to comprehend cancer development and 61 determine disease progression. However, the process of evolution is not directly 62 observed because tissues for measuring somatic mutations are typically obtained from 63 patients at a single time point. Thus, the ancestral relationship among tumor subclones 64 have to be inferred, and this is closely related to a well-studied problem, phylogenetic 65 tree reconstruction. To construct a phylogenetic tree, the mutations in each cancer cell 66 should be measured to infer evolutionary relationships among various cells. For 67 addressing this concern, the current technology of single-cell sequencing seems 68 appropriate [3, 4] . However, this technology is not widely used because of some 69 technical limitations and financial considerations [5] . Most studies on tumor evolution 70 rely on DNA sequencing technology with a bulk tumor containing genetically different 71 cells. Therefore, the cellular prevalence of each subclone have to be measured through 72 the relative read count information of the variants. 73
Single-nucleotide variants (SNVs) and copy number aberrations (CNAs) are 74 widely used data types to study tumor evolution. Recently, studies inferring the 75 population structure and clonal architecture have either focused on SNVs according to 76 variant allele frequencies (VAFs) or on CNAs with read counts obtained through DNA 77 sequencing [6, 7] . Methods for either type of data can adopt the other type of data to 78 improve their reconstruction, and most methods have developed corresponding 79 computational tools. 80
The first category of method reconstructs models with only SNV data. AncesTree 81 and clonality inference in tumors using phylogeny (CITUP) are the representatives of 82 this category, and they build models based on heterozygous SNV to study cancer 83 progression, assuming that the copy number is two [8, 9] . To relax the assumption of 84 the normal copy number status, many studies have included CNAs to correct the 85 baseline [10-13]. For instance, Pyclone is one of the clonal inference approaches, and 86 it applies a hierarchical Bayes binomial distribution to model allelic counts [13] . This 87 approach applies a Dirichlet process prior on group mutations and infers the posterior 88 distribution to estimate the cellular prevalence, which is the fraction of cancer cells 89 harboring a mutation. 90
Unfortunately, the aforementioned algorithms only considered abnormal copy 91 number states but do not infer the clonal structure of copy number changes. If we do 92 not account for clonal evolutionary architecture, the estimation of CNAs would be 93 inaccurate and just reported as an average of the CNAs of all tumor subclones. Hence, 94 in contrast to the SNV-based models, some studies focus on subclonal CNA 95 heterogeneity [7, 14-18]. They recognize that subclonal CNAs could technically 96 improve the analysis accuracy. THetA is one of the most popular tools for subclonal 97 copy number decomposition [7] ; it searches all possible combinations of copy numbers 98 across all segments and applies the maximum likelihood approach to infer the most 99 likely subclonal structures. However, THetA has an identifiability concern, such that 100 several solutions of subclone structures and copy number status levels can explain the 101 read-depth information equally well [15, 16] . 102
Integrating other data, such as single-nucleotide polymorphisms, to jointly analyze 103 tumor progression is a solution to the identification problem. The methods developed 104 on the basis of these integrated data types constitute another category of cancer 105 subclone reconstruction approaches [14] [15] [16] [17] [18] MixClone is to use the Poisson and binomial models simultaneously to analyze the read 115 depth and BAFs. 116
Most of the above mentioned methods that reconstruct the process of copy number 117 evolution assume heterozygous SNV sites within chromosome segments. This 118 assumption facilitates the decomposition of clonal CNAs, but it ignores segments 119 without any somatic SNVs. Therefore, to more effectively address this concern, we 120 developed a new algorithm, called CloneDeMix, which considers subclonal copy 121 number changes when inferring the clonal evolutionary structures. It requires only the 122 read-depth information of loci of any sizes no matter SNVs are included or not. The 123 input can be a predefined segment of the chromosome or simply a single nucleotide 124 locus. CloneDeMix is a two-way clustering model that clusters each locus into an 125 appropriate copy number state and a most likely clonal group. The procedure can 126 simultaneously evaluate all loci and regions. The algorithm uses information from all 127 samples and loci simultaneously to infer clone progression and can efficiently reduce 128 the identification bias. The flowchart of CloneDeMix is demonstrated in Fig 1. 129 In this study, we demonstrated the performance of the algorithm with simulation 130 data and applied it to a head and neck cancer dataset from The Cancer Genome Atlas 131 (TCGA) and primary esophageal squamous cell carcinoma (ESCC) [19] . The 132 simulation demonstrated the accuracy of clone identification and subclonal copy 133 number change detection, particularly in early mutational events, which could be the 134 candidate of driver mutations. The specificity of the copy number detection exceeded 135 98%, and the sensitivity was nearly 93.5%. These simulations support that our approach 136 can successfully identify the copy number mutation and deconvolute its amplification 137 or deletion state from the clonal architecture. Two-way Poisson mixture model 152 We delineated the structure of cellular evolution based on two concepts: SCP and 153 mutational cellular prevalence (MCP), as shown in Fig 2. The SCP is defined as the 154 fraction of cells that are relatively homogeneous and carry the same set of mutations. 155
The MCP is defined as the fraction of cells that carry a certain mutation. The SCPs can 156 be added to match the MCPs according to the evolutionary structure of subclones ( 
168
The read depth of each locus is proportional to the copy number and MCP. To 169 delineate the read depth of each somatic copy number variant into its copy number state 170 and MCP, this study proposes a two-way mixture model (CloneDeMix). Any locus in a 171 sample has only two states, namely normal and mutated states; the proportion of both 172 types differs across different loci. For example, locus E shows copy number changes in 173 subclone C2 but not in the other subclones ( Fig 3B) . Hence, all other subclones 174 comprise the normal allele for locus E. Furthermore, locus F has copy number changes 175 in C3, C4, and C5; hence, it is classified as normal in subclones C1 and C2. 176
CloneDeMix clusters all loci according to their copy number state and MCP. As shown 177
in Fig 3C, all loci in this case are classified into five copy number states and 178 simultaneously into five MCP levels. This results in 21 groups because we could not 179 distinguish the MCP levels for the loci of two copies. The MCPs for the five MCP 180 groups are unknown and have to be estimated. Thus, CloneDeMix provides the copy 181 number and MCP for each locus. 182
The input in CloneDeMix is the read depth of each analyzed locus. When the locus 183 represents a segment, such as an exon or a predefined amplicon, the average read depth 184 is adopted. Let Xi be the read depth of locus i or the average read depth rounded to the 185 closest integer in region i, and assume that it follows a two-way mixture Poisson 186 distribution. 187
Each component fkh(Xi) in the model represents the distribution of read depths 189 sampled from the k-th and h-th groups of the copy number state and MCPs, respectively. 190
The read count for each combined group is specified as a Poisson distribution; the mean 191 of this distribution is proportional to a function of the mutated copy number and the 192 MCP. It is specified as 193
where rh is the MCP for the h-th group, ck is the copy number of the k-th copy number 195 group, and abase,i is a normalization number for locus i. The corresponding mixture 196 weight is denoted as kh. Without further evidence, the copy number of the normal cells 197 can be considered to be two in CloneDeMix. The number of groups for copy numbers 198 and cellular proportions are pre-specified as m1 and m2, respectively; we select m1 and 199 m2 according to the Akaike information criterion (AIC). We introduce a sequence of latent binary variables for locus i. Variables = 215 { ℎ } =1,…, 1 ;ℎ=1,…, 2 take the value of 0 or 1, indicating the memberships of the copy 216 number and MCP groups for locus i. If ℎ = 1, then | ℎ = 1, , ℎ ,̂, has 217 the following distribution 218
A complete form of the conditional distribution is 219
(3)
According to the mixture model construction, the probability of ℎ = 1 is ℎ . 220
Specifically, 221
( ℎ = 1) = ℎ for each locus .
(4)
Hence, the density functions of = { ℎ } =1,…, 1 ;ℎ=1,…, 2 follow multinomial 222 distributions with probability functions 223
(5)
According to the definition of conditional probability, the joint density function of 224 and can be written as follows: 225
(6)
The log likelihood of Π and ̃ is 226
Because there is no closed form for the maximum likelihood estimator of Π and 227
, we adopted the EM algorithm to determine the MLE. The EM algorithm iteratively 228 maximizes the expected log likelihood in two steps: E and M steps. 229
The E step of the EM algorithm determines the expected value of the log likelihood 230 over the value of the latent variable Y, given the observed data X and current parameter 231 value Π = Π 0 and ̃=̃0. Thus, we derive the following equation: 232 |Π 0 , ,̃0, [ (Π,| , , )]
According to the definition of ℎ , 233
and substitute it into equation (8); with some 234 arrangement, we obtain 235
The M step of the EM algorithm maximizes equation (10) over Π,̃ to determine 236 the next estimates (e.g., Π 1 and ̃1). The maximization over Π involves only the 237 second term in equation (10): 238
The solution is
/ . The maximization of ̃ concerns the first 239 term of equation (10), and the solution has no closed form. Numeric algorithms, such 240 as the Newton-Raphson method, are required to solve the equation. We used the 241 Newton-Raphson method with the R function optim(), and the iterative algorithm for 242
The solutions (Π 1 ,̃1) are substituted into equation (10) to replace (Π 0 ,̃0). The 244 expectation is then rewritten as signed-rank test can be applied to the profiles of the two mutations. In the event of 256 significant inequality, when one mutation is more common in cells than the other 257 mutation, it indicates a recurrent evolutionary order between the two mutations. 258 259
Results

260
In this study, we first evaluated the prediction accuracy of CloneDeMix by 261 simulated data. Simulation study is useful to verify how well an algorithm behaves with 262 data generated from the theory, but it cannot inform us how well the theory fits reality. 263
To that end, we collected normal RNA sequences from TCGA and applied down-264 sampling to these normal data to create artificial copy number changes. We used the 265 data to compare CloneDeMix with THetA by evaluating weighted root mean square 266 error of MCP estimation and positive rate of copy number prediction. We also applied 267
CloneDeMix on head and neck cancer data from TCGA and serial biopsies of 268 esophageal cancer [19] to infer genomic evolution based on copy number change. 269
Simulation 270
The simulation considered four variant states of copy numbers, namely 0, 1, 3, and 271 4 copies. Four MCPs were included: 0.1, 0.3, 0.5, 0.7, and 0.9. Each combination was 272 repeated three times, thus resulting in 60 regions with copy number changes. 273 Furthermore, each region was assigned 20 bases generated with a Poisson distribution 274 whose mean value was determined by its assigned copy number state and MCP. In 275 addition to the mutated regions, 100 normal regions were scattered among the mutated 276 regions; their copy number state was two. The simulation generated depths for a long 277 sequence with 3,200 bases for each of the 60 samples. CloneDeMix was subsequently 278 applied to the simulation data to reconstruct respective copy number states and MCP 279 groups. The entire simulation process was repeated 10,000 times to obtain a conclusion. 280
The simulation was performed to evaluate the model estimation accuracy. Table 1  281 shows the mean and standard deviation (SD) of simulation results for MCP estimation, 282
and Fig 4 demonstrates the accuracy of assignments for copy number states. As 283 presented in Table 1 , the MCP estimates were very close to the underlying truth, 284 indicating high performance for MCP estimation. Notably, the bias decreased as the 285 ground value of the MCP increased. Detecting mutations of low cellular prevalence was 286 relatively difficult because the signal was not adequately strong. 287
As illustrated in Fig 4, the accuracy of the copy number assignment under each 288 condition was calculated from 10,000 simulations. The specificity of CloneDeMix was 289 found to be 99.58%, and the sensitivity for amplification and deletion were 93.65% and 290 93.89%, respectively. Thus, CloneDeMix represents a high specificity and efficiently 291 controls false positive results. As mentioned in the discussion on MCP estimation, 292 estimating mutations of low cellular prevalence was biased. These biased MCPs 293 directly caused the misclassification of the copy number state and reduced the model 294 sensitivity. In conclusion, these simulations support that CloneDeMix can successfully 295 identify the potential copy number mutations and deconvolute its amplification or 296 deletion state from the clonal architecture. 297 298 
. Result of copy number estimation
The size of the circle is proportional to the number of loci assigned to each estimated status from 10,000 simulations. The CNA status is divided into three conditions: deletion, amplification, and normal conditions. 301 302
Comparison with THetA2
303
In this section, we evaluated CloneDeMix on a more realistic simulation scenario 304 and compared it with THetA2. The core concept of this simulation scenario is the use 305 of down-sampling technique to resample reads of real normal sequencing data with 306 artificial copy number changes. 307
To that end, we first collected 75 normal samples from TCGA and then performed 308 standard quintile normalization to reduce noise. For simplicity, we only used 309 chromosome 1 for validation, and chromosome 1 was first cut into 200 different regions. 310
According to the raw data, we have the raw read counts of each region per sample. The 311 75 samples were equally divided into case and control. In the control group, the 312 resampled read count of each region was generated from a binomial distribution. For 313 the parameter setting of a binomial distribution, the number of trials is set as two times 314 raw read count and the success probability is 0.5. This procedure is called down-315 sampling and it guarantees the mean of resampled count is the same as the mean of raw 316 count. In the case group, we need to randomly assign 20 regions to have copy number 317 change. The resampled read count of CNA region also followed the binomial 318 distribution with the number of trials equal to two times of the raw read count, but the 319 success probability is set as 0.5×(2×(1-MCP)+C×MCP)/2 which is determined by a 320 predefined copy number C and MCP. The predefined copy number of a variant was set 321 to be 0, 1, 3, and 4. The MCP was set to be 15 different values ranging from 0.1 to 0.9 322 as shown in Fig 5.  323 Most studies integrate CNAs and single nucleotide change to improve the accuracy 324 of copy number identification and to reduce the bias of cellular prevalence estimation. 325
However, those approaches only study the regions that contain single nucleotide change, 326 and this constraint apparently limits our understanding of the chromosome structure 327 change. It has been reported that CNAs affect a larger fraction of the genome in cancers 328 than any other type of somatic genetic mutation does [23] . For example, a large-scale 329 study of somatic CNAs across different cancers shows that in a typical cancer sample, 330 17% of the genome was amplified and 16% genome was deleted on average [24] . Hence, 331 for a fair comparison, we only compared CloneDeMix with THetA2 because THetA2 332 is also a subclonal copy number decomposition method and supports direct tumor 333 heterogeneity inference without considering SNVs. 334
Both of CloneDeMix and THetA2 are developed for multiple clone identification, 335 but THetA2 tends to identify single clone in our experience. Therefore, we designed 336 the resampled data as a mixture of normal cells and one subclone of tumor cells. In this 337 simple case, the MCP is equal to the tumor purity and we explored the model 338 performance in different purity. In Fig 5A, the cyclic loess method and was subsequently processed through CloneDeMix to 367 identify the copy number status at each locus. In this step, the average profile of all 368 other normal samples was treated as the baseline. If, for example, an abnormal copy 369 number is found to be k, the raw read depth of this locus would be divided by k to 370 provide the estimate of , for tumor modeling. 371
Copy number distribution and clone structure 372 We applied CloneDeMix to each normalized sample and estimated the copy 373 number state of each locus as well as the corresponding MCPs. Fig 6A shows On average, 4.7% and 8.7% of exons were estimated to have deletion and 384 amplification, respectively. We also found that the exons located at 3p, 21p, and 18q 385 were deleted most frequently, and the average proportions of deletion within these 386 chromosomal arms were 19%, 17%, and 13%, respectively. Conversely, the estimated 387 amplification frequently occurred at 3q, 8q, and 5p, with average frequency levels of 388 29%, 24%, and 23%, respectively. Previous studies have reported a loss of 3p and 8p 389 as well as gains of 3q, 5p, and 8q not only in head and neck cancer but also in most 390 tumors [20-23]; these results are concordant with our findings. Other novel subclonal 391 CNA regions that were not reported in pan-cancer data analysis [20-23] were identified 392 as multiple tumor subpopulations were considered (e.g. Deletion in 21p, S1 Fig There appeared to be a tendency of increased tumor heterogeneity for tumors with 407 invasion or metastasis. The variation of numbers of MCPs was larger for this group. To 408 more comprehensively clarify this factor, we dichotomized the number of MCPs into 409 two groups. The number of MCPs exceeding 4 indicated strong tumor heterogeneity, 410 whereas a lower number indicated less heterogeneity. The contingency table (Fig 7B)  411 shows the dichotomization of tumor heterogeneity associated with the clinical 412 outcomes. The corresponding odds ratio was 3.64, and the p value evaluated with 413 logistic regression was 0.029. For the samples with higher tumor heterogeneity, the 414 odds of invasion and metastasis were 3.64 times higher than those for the samples with 415 lower tumor heterogeneity. In recent studies of head and neck cancer, this association 416 between tumor heterogeneity and metastasis was explored by whole exome sequencing 417 and single cell RNA sequencing [25] [26] [27] . These studies also found the difference in 418 tumor heterogeneity between primary and matched lymph node metastases samples. 419
We further investigated the association of overall patient survival and tumor 420 heterogeneity by survival analysis, and used two different ways to demonstrate this 421 association. First, we directly considered the subclone number as a covariate of survival 422 analysis, and then applied Cox model to analyze the effect of subclones. We got a p-423 value, 0.036, by Wald's test, and apparently tumor heterogeneity is a risk factor for 424 survival. Next, we considered three different tumor heterogeneity levels of samples and 425 
Inference of evolutionary order of mutations 440
As stated in the Methods section, we inferred the evolutionary order of recurrent 441 variants with multiple samples. For easy comprehension, we demonstrated the result at 442 the gene level through a series of summary steps. We first selected the genes with 443 consistent amplification or deletion states in more than 25% of the exons within at least 444 one sample. A total of 3,244 genes were included in this demonstration, and this set is 445 called the background gene set. For each sample, the MCP of a gene was represented 446 by the mean MCP of its exons. We then performed the Wilcoxon signed-rank test using 447 the gene-level MCP of any two genes across the samples to derive all pairwise 448 evolutionary relationships. For example, if the MCP of gene i was larger than that of 449 gene j (p = 0.05), the mutation on gene i was more likely to be an earlier event than that 450 on gene j. This relationship was marked as 1; otherwise, it was marked as 0. The 0-1 451 matrices of pairwise evolutionary relationships were separately calculated for samples 452 with and without nodal metastasis, and they could be denoted as a matrix and 453
. The element of the matrix could be denoted as , , representing the 454 evolutionary order of mutations on gene i against mutations on gene j inferred with 455 samples under the E condition, which could be neg or pos. 456
The evolutionary order matrix can be used to construct an evolutionary tree of all 457 mutations. However, a tree of 3,244 genes is highly complicated, rendering the 458 comparison of different clinical traits difficult. Therefore, for simplification, we 459 proposed a progression score to summarize the relative position of a mutation on the 460 evolutionary tree of tumor formation. The scores of a gene in advanced tumors can be 461 compared with those of genes in newly developed tumors to select the ones that 462 recurrently occur in the early stage of tumor development. The P score of gene i under 463 condition E is thus defined as a summary statistic from the evolution matrix and is 464 formulated as follows: 465
Among all relations of gene i with other genes, the P score provides the number of times 466 the mutation in gene i is more likely to occur before that in other genes. If a gene is 467 close to the root of an evolutionary tree, its corresponding P score must be higher than 468 that of its descending gene. 469
We first investigated the P-score behavior of prevalent genes which have been 470 discussed in head and neck cancer [22] , and the results are listed in Table 2 . The P-score 471 of PIK3CA is consistently larger than 0.9 across different clinical traits. That is, the 472 mutation of PIK3CA occurs early in the tumor progression. In contrast, patients with 473 perineural invasion acquire early mutation of CDKN2A gene more often. Some of the 474 well-known cancer genes are not powerful in our P-score analysis. For example, we 475 identified structure variation of TP53 only in a few patients, and these few MCPs are 476 not enough to construct a powerful P-score. 477
We compared the P score between the samples with and without nodal metastasis 478 by plotting a scatter plot (Fig 9) . Most background genes tend to mutate in a random 479 order not related to tumor progression. According to our P score definition, we 480 postulated that the driving genes of lymph node metastasis would be scattered above 481 the diagonal line. The genes above the diagonal line of the plot are more likely to 482 acquire mutations at an earlier stage of tumor formation and occupy a significant 483 proportion of the tumor at its advanced stage. This would yield higher P scores when 484 only the samples with lymph node metastasis are considered. By contrast, the 485 prevalence of mutations in those genes might be low in the samples without lymph node 486 metastasis and hence yield lower P scores. 487 488 
492
To confirm our conjecture, we selected the genes by their biological functions using 493
ConsensusPathDB web (http://cpdb.molgen.mpg.de/) and investigated whether genes 494 related to metastasis in the literature are more likely to be distributed above the diagonal 495 line. Because cell migration is a crucial step in the metastatic cascade, we selected cell-496 migration-related genes, which are marked as black in Fig 9. Consequently, we found 497 that 43 genes had the function of cell migration. Most of these genes were distributed 498 above the diagonal line of the P score scatter plot, whereas some were distributed below 499 the diagonal line. Recurrent mutations in these cell migration genes are expected to be 500 the driving forces for the initiation of lymph node metastasis, consistent with our 501 observations. For example, HAS2 is a member of the gene family encoding putative 502 hyaluronan synthases, which control the biosynthesis of hyaluronan and critically 503 modulate the tumor microenvironment. Several studies have shown that the inhibition 504 of HAS2 reduced the invasion of oral squamous cell carcinoma [28] [29] [30] . Similar to 505 HAS2, ANGPT1 is located in the upper left corner and has been recently investigated 506 for the mechanism of lymph node metastasis [31] [32] [33] [34] . ANGPT1 plays an important role 507 in the regulation of vascular development and maintenance of vessel integrity. A study 508 showed that the activity of ANGPT1 induced the enlargement of tumor blood vessels 509 to facilitate tumor cell dissemination and increased the ability of metastasis in tumors 510 [34] . Fibroblast growth factor (FGF)-4 is another notable example. The P score of FGF4 511 significantly differs in nodal positive and negative patients. FGF4 is a member of the 512 FGF family and possesses broad mitogenic and cell survival activities. It has been 513 proposed to be involved in tumor growth, cell proliferation, and lymph node metastasis 514 [35] [36] [37] . In contrast to the black genes located in the upper left corner of the plot in Fig  515   9 , few studies have reported any relationship between the black genes located in the 516 lower right corner and lymph node metastasis, although they have the same biological 517 function. A complete literature review of the genes associated with cell migration and 518 tumor metastasis is presented in S1 Table. The observations suggest that our inference 519 of the clonal evolutionary order is relevant and can be applied for identifying causal 520
drivers. 521
Another notable observation is about the neighboring genes of FGF4. As 522 mentioned, FGF4 is an important gene for driving lymph node metastasis. It is located 523 in 11q13.3, which is frequently amplified in head and neck squamous cell carcinoma 524 [35] . Sugahara also listed several other genes in 11q13.3 that are related to cancer 525 development, namely TPCN2, MYEOV, CCND1, ORAOV1, TMEM16A, FADD, 526 PPFIA1, CTTN, SHANK2, and DHCR7. We also assessed their status by using the P 527 score analysis; the genes are indicated in blue in Fig 9. All these genes were above the 528 diagonal line. Their corresponding P scores showed considerably significant differences 529 between patients with and without nodal metastasis. Hence, we postulated that those 530 genes in 11q13.3 are possibly related to lymph node metastasis in head and neck cancer. 531
Several previous studies have confirmed this observation, as reported in S2 Table.  532 533 Application on serial biopsies of esophageal cancer 534 We next applied CloneDeMix on multiregional whole-exome sequencing data from 535 13 primary esophageal squamous cell carcinoma (ESCC) patients [19] . There are 51 536 tumor regions and 13 matched morphologically normal esophageal tissues sequenced 537 with the mean coverage of 150×. For fair comparison, we selected 11 of 13 patients 538 based on its platform. We also removed patient ESCC07 because we only got two 539 regions successfully aligned to the reference genome. In total, we included 10 patients 540 in this application, and, for each patient, we have four different tumor regions with one 541 matched esophageal tissue. As preprocess of TCGA data, the read-depth profiles of 542 ESCC tumors are normalized with loess transformation against its paired normal 543 sample. For each individual, the paired normal tissue is also used to calculate the 544 estimates of baseline, and then applied CloneDeMix to tumors for gene-specific CNVs 545 and MCPs. 546
In this application, we aim to explore the variability of evolutionary structure 547 among multiregional tumors by inferring the order of copy number change. For the 548 purpose of studying variability between regions, we only focused on the frequently 549 mutated genes which are informative about tumor evolution. Although the construction 550 through these genes is not able to resolve completely the entire evolutionary structure, 551 the inferred structure between regions can still facilitate the understanding of tumor 552 progression. To that end, we collected the target gene list from the Ion AmpliSeq 553
Comprehensive Cancer Panel which includes 7,044 exons of 409 tumor suppressor 554 genes and oncogenes. The estimated CNVs and MCPs of the ESCC biopsies for this 555 gene set were summarized and interpreted as follows. 556
We first investigated genomic heterogeneity of ECSS through MCP comparison. 557 MCP is a gene-specific measurement of fraction of cells that carry a certain mutation, 558 and we can study the overall structure of MCPs across whole genome to reveal the 559 genomic heterogeneity of a given sample. We calculated the correlation matrix of MCP 560 between samples, and this correlation matrix is presented in Fig 10. The diagonal blocks 561 of this correlation matrix are tissues of the same sample and are slightly higher than the 562 others. The average correlation of diagonal block is 0.5 and the average of off-diagonal 563 cells 0.3. It shows that the MCP structure within each patient is more consistent than 564 between patients. 565
Next, we identified the evolution-related genes for each individual. In ESCC study, 566 each tumor was dissected into four regions, and this kind of serial biopsies has a natural 567 assumption that the size of MCPs is comparable within a given tumor. This 568 characteristic can facilitate the individual-specific heterogeneity study. In order to 569 explore individual-specific heterogeneity, we first identified genes on the trunk and on 570 the branch of the evolutionary tree separately. The trunk of the tree refers to the CNAs 571 consisted in all regions while the branch refers to those only in some regions. We can 572 identify these genes according to the MCP across regions. A gene is located on the trunk 573 of a tree if its average MCP across four regions is larger than 0.8, and a gene is located 574 on the branch of a tree if the MCP of one region is larger than the average MCP of all 575 the remaining regions by 0.7. Instead of tree comparison, we directly compare the MCP 576 matrix of selected genes (Fig 11) . In Fig 11, genes in red rectangles are selected to be 577 the trunk genes, and the remaining genes are on the branch of a tree. 578
The two types of genes defined above reveals huge variability of evolution 579 structure across tumors. The genes on the trunk of a given tree represent the genes 580 changed in copy number at an earlier stage of tumor formation, and these genes have 581 potential ability to drive tumor growth. In this study, we developed CloneDeMix for the deconvolution of tumor 596 progression through high-throughput DNA sequencing data. The features of 597 CloneDeMix are as follows. First, it reconstructs an evolutionary structure of copy 598 number changes during tumorigenesis. Most existing methods for cancer evolution 599 discuss the history of single-nucleotide changes and derive the potential driver genes. 600 However, the importance of CNAs is growing and its influence on disease and cancer 601 development is clearly established [44] . Therefore, the reconstruction of copy number 602 evolution in tumor progression is in demand. Second, CloneDeMix provides the MCP 603 as a measure of the evolutionary structure. This measurement is used to estimate the 604 fraction of cells containing a specific set of mutational events. According to the 605 definition of the MCP, it provides a more direct evolutionary reconstruction than does 606 the SCP, which is defined as the size of a subclone in a tumor. For instance, the MCPs 607 of early mutations in cancer must exceed those of other mutations, but no such structural 608 relationship exists for SCPs. Although MCPs of a tumor is related to its phylogenetic 609 tree, we do not have DNA haplotypes to resolve the tree architecture from many 610 possibilities for each individual tumor. Hence, in this study, we only borrow the strength 611 of multiple samples to understand potential evolutionary orders using the P score. Third, 612 our model exhibits high flexibility. CloneDeMix can identify the copy number state of 613 any type of variant, from a single nucleotide to a moderate size of regions. Furthermore, 614 the model facilitates the simultaneous analysis of multiple types of targets because it 615 depends on only the summary information of each locus. 616
The simulation study revealed that CloneDeMix can identify the current clonal 617 structures of a tumor. The accuracy of copy number states was nearly 93%, and the 618 MCP was also accurately restored (Table 1) . Furthermore, the application of 619 CloneDeMix to head and neck cancer data from TCGA yielded promising putative 620
CNAs. The deletions observed on chromosomes 3p, 18q, and 21p and the 621 amplifications on chromosomes 3q, 5p, and 8q are consistent with most cancer studies 622 on copy number identification [20-23]. This observation strongly supports our CNA 623 inference procedure. 624
When the estimation accuracy reaches a certain level, the most important concern 625 is to understand the relationship between tumor heterogeneity and disease progression. 626
Tumor clone dynamics have been associated with clinical outcomes for different types 627 of cancer [45] [46] [47] . Our method provides a quantitative measurement of clonality, and it 628 is associated with tumor invasion and metastasis development in TCGA database. 629
Tumors with more subclones are a result of complex branched evolution, implying a 630 series of adaptations to a new environment. These newly emerged subclones may 631 contribute to metastatic initiation or acquire a new ability to invade the lymphatic or 632 vascular system. Thus, the strong prognostic association of the number of MCPs with 633 invasion or metastasis reinforces its clinical relevance; this index appears to be a novel 634 feature for further exploration. 635
We established a novel score, the P score, for evaluating the order of a recurrent 636 mutation in the evolutionary hierarchy by analyzing multiple samples. By comparing 637 the P scores of a somatic variant between different clinical groups, we could identify 638 the copy number mutations that occur early in the tumor stage and expand the 639 accompanied subclones with time. The utility of P scores was also demonstrated in the 640 head and neck cancer data according to the sample status of metastasis. Furthermore, 641
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